Thursday 28 May 2020
Home      All news      Contact us      English
sputniknews - 6 days ago

RDIF, ChemRar Name New Drug Undergoing Trials to Treat COVID-19 Avifavir

MOSCOW (Sputnik) - A new drug that has shown its effectiveness at combating COVID-19, which is being produced as a joint venture between the Russian Direct Investment Fund (RDIF) and the ChemRar Group, will be called Avifavir, according to a statement published by the RDIF on Friday.


Latest News
Hashtags:   

ChemRar

 | 

Undergoing

 | 

Trials

 | 

Treat

 | 

COVID

 | 

Avifavir

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources